Spinal bulbar muscular atrophy is a neurodegenerative disorder caused by a polyglutamine expansion in the androgen receptor (AR). We show in transiently transfected HeLa cells that an AR containing 48 glutamines (ARQ48) accumulates in a hormone-dependent manner in both cytoplasmic and nuclear aggregates. Electron microscopy reveals both types of aggregates to have a similar ultrastructure. ARQ48 aggregates sequester mitochondria and steroid receptor coactivator 1 and stain positively for NEDD8, Hsp70, Hsp90 and HDJ-2/HSDJ. Co-expression of HDJ-2/HSDJ significantly represses aggregate formation. ARQ48 aggregates also label with antibodies recognizing the PA700 proteasome caps but not 20S core particles. These results suggest that ARQ48 accumulates due to protein misfolding and a breakdown in proteolytic processing. Furthermore, the homeostatic disturbances associated with aggregate formation may affect normal cell function.
INTRODUCTION
Spinal bulbar muscular atrophy (SBMA) is a rare X-linked hereditary disease characterized by progressive muscle atrophy and weakness in patients beginning at ∼30-50 years of age and is caused by degeneration of motor neurons (1, 2) . Mapping studies (3, 4) and the finding that SBMA patients show partial androgen insensitivity (5) have implicated the AR gene in this disease. Expansion of a trinucleotide CAG repeat in the first exon of AR has been identified in SBMA patients (6) and produces a large polyglutamine (polyQ) tract. The length of the polyQ tract is polymorphic in the population ranging in size from 10 to 36 repeat units in normal individuals and from 40 to 62 repeat units in SBMA patients. PolyQ expansion is also associated with several other neurodegenerative diseases, including Huntington's disease (HD), dentatorubral and pallidoluysian atrophy (DRPLA) and spinocerebellar ataxia (SCA) 1, 2, 3, 6 and 7 (7) (8) (9) (10) (11) (12) (13) . Many of these diseases are characterized by atrophy and loss of selected populations of neurons and development of inclusions containing mutant proteins (14) (15) (16) (17) (18) . Intranuclear inclusions containing ataxin-1 and huntingtin are also found to be ubiquitin immunopositive and, recently, AR-and ubiquitin-positive cellular structures have been identified in an SBMA patient (14, (16) (17) (18) (19) . Moreover, cellular aggregates of ataxin-1 immunolabel with antibodies specific for inducible Hsp70, HDJ-2/HSDJ and proteasome components (20) . These data collectively suggest that abnormal protein folding leads to aggregation and proteasome redistribution and thereby offers a potential mechanism by which toxic polyQ proteins cause neurodegeneration.
An advantage of studying polyQ AR is that a large body of data has accumulated on wild-type AR function, intramolecular domains and interactions with steroid receptor cofactors and molecular chaperones (for reviews see refs [21] [22] [23] [24] . Unliganded steroid receptors exist in the cytoplasm as a complex containing several molecular chaperones, including Hsp90, Hsp70 and Hsp56 (25, 26) . Binding of hormone to the C-terminal ligand binding domain of AR results in shedding of heat shock proteins and translocation to the nucleus (27, 28) . Interactions with steroid receptor coactivators and DNA leads to the expression of specific DNA target sequences (22, 29) . Several mutations in AR, especially in the DNA binding domain, result in the formation of both cytoplasmic and nuclear aggregates that rapidly form only in the presence of hormone (30; L.V. Nazareth, D.L. Stenoien, W.E. Bingman III, A.J. James, C. Wu, Y. Zhang, D.P. Edwards, M.A. Mancini, M. Marcelli, D.J. Lamb and N.L. Weigel, submitted for publication). This suggests that in the absence of hormone, the association of mutant ARs with cytoplasmic chaperones may play a role in stabilizing AR and preventing aggregate formation. It should be noted, however, that mutations in the DNA binding domain lead to aggregates that are different in terms of the dynamics of their formation, ultrastructure and association with other cellular components than the polyQ aggregates.
Several recent studies have used cell culture models to investigate the properties of polyQ ARs compared with wild-type AR. When transfected into neuroblastoma cells, an AR containing 52 CAG repeats was shown to undergo cleavage of the C-terminal ligand binding domain and accumulate in cytoplasmic aggregates following 1 h of hormone treatment (31) . Merry et al. (32) also found that cytoplasmic aggregation and proteolytic processing of AR occurred in a polyQ repeat length-dependent manner and this aberrant metabolism was coupled to cellular toxicity. Collectively, both groups demonstrated that polyQ ARs accumulate in cytoplasmic aggregates visualized by immunofluorescence microscopy. In addition, a recent brief report has shown that polyQ AR accumulates in ubiquitin-positive aggregates in the cell nuclei of patient tissue (19) . This suggests that neuronal aggregates may be important for development of SBMA, as in the case of SCA1, SCA3 and HD.
While there appears to be a strong correlation between the occurrence of cellular inclusions and polyQ diseases, two recent reports have suggested that aggregate formation itself is not required for disease initiation. Aggregate formation by mutant huntingtin protein was not correlated with onset of cell death in transfected cells (33) . In addition, transgenic mice expressing mutant ataxin-1[77Q] without a self-association domain develop ataxia and Purkinje cell pathology similar to that described for full-length ataxin-1[82Q] without forming detectable ataxin-1-positive aggregates (34) . Though this result indicates that formation of aggregates is not required for initiation of SCA1 pathogenesis, aggregates may play a role in disease progression.
We show here that an increased frequency of hormone-induced AR aggregate formation occurs in a polyQ tract length-dependent manner. Using a green fluorescent protein (GFP)-ARQ48 chimera to study the dynamics of aggregate formation in live cells we demonstrate that aggregates can form immediately after hormone addition or during mitosis when nuclear patches of ARQ48 reorganize into cytoplasmic aggregates. Antibodies specific for cell stress proteins label ARQ48 aggregates. Moreover, ARQ48 aggregates differentially sequester proteasome components, mitochondria and the steroid receptor coactivator, SRC1. As shown for intranuclear aggregates containing mutant glucocorticoid receptor (35) and ataxin-1 (20) , a compensatory increase in cellular levels of the molecular chaperone HDJ-2/HSDJ significantly reduce the formation of cytoplasmic ARQ48 aggregates. Taken together, these data support the idea that the polyQ expansion of AR leads to misfolding and elicits a cell stress response that disrupts normal protein turnover dynamics. Furthermore, disturbances in the homeostatic balances of chaperones, proteasomes, steroid receptor coactivators and ATP may adversely affect cell function.
RESULTS

ARQ48 forms hormone-dependent aggregates
To test the effects of polyQ tract length on aggregate formation in transfected cells, we used three AR constructs containing 0 (ARQ0), 22 (ARQ22) and 48 (ARQ48) glutamine repeats (Fig.  1A) . Western blots of cell lysates from transfected cells revealed a ladder corresponding to the differences in molecular weight and that relatively equal amounts of protein were expressed (Fig. 1B) . When transfected cells were analyzed by immunofluorescence, all three proteins were predominantly cytoplasmic in the absence of hormone but adopted a nuclear distribution in the presence of hormone (Fig. 1C) . In some cells expressing large amounts of protein, non-distinct cytoplasmic aggregates were observed (Fig.  1C , left, and D, top left). However, these hormone-independent aggregates did not appear to be polyQ-dependent as they were present in cells expressing ARQ0 and ARQ22. In the presence of hormone a distinctly different type of cytoplasmic aggregate occurred that was closely correlated with polyQ tract length (Fig.  1D , top right, and Table 1 ). Since AR has a tendency to aggregate when overexpressed, we wanted to ensure that the hormoneinduced cytoplasmic aggregates were dependent upon polyQ tract length. By transfecting equal amounts of DNA and checking protein expression levels by western blot analysis, a clear correlation was found between the appearance of aggregates and polyQ tract length (Table 1 ). In cells expressing ARQ48, cytoplasmic aggregates were found in ∼25% of transfected cells, while this percentage dropped to 12.2% for ARQ22 and 6.7% for ARQ0. Cells expressing GFP-ARQ48 had a higher propensity to form detectable cytoplasmic aggregates (37% compared with 26%; Table 2 ). An increase in detectable aggregates was also observed with GFP-ARQ0 and GFP-ARQ22 (12.5 and 23%, respectively, compared with 6.7 and 12.2% for untagged ARQ0 and ARQ48, respectively). It is unclear whether this increased aggregate formation was due to the GFP or if GFP increases the ability to detect aggregates that are relatively impermeable to many antibodies. It is important to note that the dependence of polyglutamine tract length on the frequency of aggregate formation was maintained in the GFP constructs. There appears to be a cell cycle component to the appearance of these aggregates as they reached a peak at ∼16 h after hormone addition and they were often found to form during mitosis (see below).
Immunofluorescent labeling with anti-androgen receptor antibodies revealed a ring-like labeling pattern of the aggregates. This appearance was also observed with some but not all antibodies used for co-localization experiments (see below) and suggests a differential accessibility of epitopes within these structures. In differential interference contrast (DIC) microscopy (Fig. 1D , bottom left) the aggregates appeared solid with the exception that 'holes' were sometimes observed. When cells were transfected with a GFP-ARQ48 construct, the bioluminescence appeared throughout in a non-homogeneous pattern indicating that ARQ48 is not confined to the periphery (Fig. 1D, bottom right) .
High magnification electron microscopic images revealed a dense granular appearance of the ARQ48 aggregates ( Fig. 2A) . Immunogold labeling showed that ARQ48 is present throughout the dense fibrogranular regions and is excluded from the electronlucent regions (Fig. 3) . Analysis of the nuclei of cells containing ARQ48 cytoplasmic aggregates showed dense nuclear patches of Immunofluorescence was performed on HeLa cells transfected with each of the three AR constructs in the presence and absence of hormone, using charcoal-stripped serum-supplemented medium. All three ARs were cytoplasmic in the absence of hormone. (C) Some cells that express a relatively higher amount of AR contain non-distinct cytoplasmic aggregates (left). In the presence of hormone all three ARs were found in the nucleus with the exception that large, round cytoplasmic aggregates were frequently observed in cells expressing ARQ48 (right). (D) Higher resolution images show the differences between the non-distinct aggregates that form in the absence of hormone (top left) and those aggregates that form in a hormone and polyglutamine tract length-dependent manner (top right). By DIC (bottom left), ARQ48-positive structures have a solid appearance with the exception that dimples or holes can be seen in some. A high resolution image using a GFP-ARQ48 construct and deconvolution microscopy shows aggregates with a honeycombed appearance (bottom right). Bars, 10 µm.
ARQ48 with a similar ultrastructure (Fig. 2B ). These nuclear patches were difficult to detect by immunofluorescence microscopy although they were immunogold-positive for AR (Fig. 3) . Interestingly, the cytoplasmic ARQ48 structures appeared to recruit mitochondria ( Fig. 2A and B) ; in some cells virtually the entire cellular pool of mitochondria was associated with these structures (Fig. 2C ). This observation indicates that large amounts of energy are required for the formation and maintenance of the ARQ48 aggregates. The ultrastructure of the cytoplasmic and nuclear aggregates suggests that they may form by similar mechanisms. Moreover, the cytoplasmic aggregates that we observed may have a nuclear origin since, in most cells, cytoplasmic aggregates appeared following cell division (see below). ARQ48 was co-transfected with empty vector, wild-type HDJ-2/HSDJ or HDJ-2/HSDJ∆450 and the effects on aggregate formation were determined by counting the number of co-transfected cells containing aggregates. Five separate co-transfection studies were performed for each construct. The total number of AR-positive cells and aggregate-containing cells from one coverslip were counted for each transfection experiment and the percentage of cells containing aggregates was determined. The percentages from the five experiments were averaged. The level of repression observed between empty vector and wild-type HDJ2/HSDJ is significant (P < 0.0005).
Dynamics of aggregate formation
To address the issues of the timing and mechanism of aggregate formation, GFP-ARQ48 was used for live cell analysis. In the absence of hormone, GFP-ARQ48 had a similar cytoplasmic distribution to both wild-type AR and untagged ARQ48 (Fig. 4A , left). The addition of hormone resulted in the rapid translocation of GFP-ARQ48 to the nucleus. In most cells, the entire cytoplasmic pool of GFP-ARQ48 translocated to the nucleus within 20 min where it had a similar distribution to ARQ22 and ARQ48 (Fig. 4A , bottom cell). However, in some cells, cytoplasmic aggregates were observed to form rapidly after hormone addition (Fig. 4A , top cell) indicating that GFP-ARQ48 structures can form in the cytoplasm prior to nuclear translocation. Observation of cells for longer periods of time demonstrated that GFP-ARQ48 structures also formed during mitosis. Several cells in various stages of aggregate formation are shown in Figure 4B . Two of the cells that appeared to be twin daughter cells contained very prominent cytoplasmic aggregates. Adjacent to these cells is a prometaphase cell that appears to be in the process of forming aggregates. The inset shows an anaphase cell with aggregates. Interestingly, ARQ48 appeared to coat the chromosomes during mitosis. This association of ARQ48 with mitotic chromosomes was also observed with the wild-type AR (data not shown). Live analysis of the cytoplasmic aggregates revealed that smaller aggregates can move and fuse to form larger aggregates (Fig. 4C ). It is unknown at this time whether aggregates move and fuse through random movements or if they undergo some type of directed movement involving motor proteins. Indeed, the varied density of the aggregates by electron microscopy (EM) may reflect different stages of fusion.
ARQ48 aggregates co-localize with heat shock proteins
AR associates with several molecular chaperones including Hsp70, Hsp90 and HDJ-2/HSDJ. These chaperones aid in stabilizing both unliganded and liganded AR and assisting in the conformational changes that occur upon hormone binding and translocation to the nucleus (27, 28) . To determine whether ARQ48 altered either the expression levels or localization of molecular chaperones, co-localization experiments were performed with relevant antibodies. We first examined if ARQ48 elicited a heat shock response by double labeling cells with antibodies specifically recognizing the inducible form of Hsp70.
As shown for wild-type AR (36), we found increased staining of Hsp70 in cells containing ARQ48 in both the nucleus and cytoplasm; moreover, ARQ48 aggregates were intensely Hsp70 positive ( Fig. 5A and B) . ARQ48-positive structures also stained with antibodies recognizing Hsp90 ( Fig. 5C and D) but labeling with antibodies recognizing other Hsps, including Hsp25, Hsp27 and Hsp110, was negative (data not shown). Labeling studies with antibodies recognizing HDJ-2/HSDJ also demonstrated that ARQ48-positive nuclei and aggregates accumulated HDJ-2/HSDJ ( Fig. 5E and F) . Taken together, these data indicate a direct relationship between expression levels and organization (aggregates) of ARQ48 and several, but not all, chaperones and suggest that a cell stress response is elicited by the presence of ARQ48 aggregates.
Co-expression of HDJ-2/HSDJ reduces aggregate formation
The finding that cellular ARQ48 is associated with molecular chaperones and elicits a heat shock response suggests that protein misfolding leads to aggregate formation. Bacterial and eukaryotic DnaJ proteins have been shown to play important functional roles in protein folding and aggregation suppression (37, 38) . Moreover, Tang et al. (35) and Cummings et al. (20) have reported that overexpression of HDJ-2/HSDJ significantly suppresses the formation of nuclear aggregates containing mutant glucocorti- Immunogold labeling reveals nuclear and cytoplasmic aggregates of ARQ48 label with AR, p31/PA700, but not 20S antibodies. Immunogold co-labeling using different size gold particles was performed using anti-AR, anti-p31 and anti-20S antibodies to identify cytoplasmic aggregates (A and B) or nuclear patches (C and D) of ARQ48. Consistent with the immunofluorescent results, antibodies to AR (6 nm gold) and p31 (12 nm gold) label throughout the cytoplasmic aggregates (A) whereas little 20S labeling is found in the interior (B). AR and p31 labeling is also seen in the nuclear patches (C) (AR = 12 nm, p31 = 6 nm). Labeling of 20S is observed in the cytoplasm and at the periphery of some aggregates (20S = 12 nm) (B) indicating that the fixation procedure does not inhibit 20S immunogold labeling. The nuclear patches of ARQ48 label with anti-AR (12 nm) and also appear to exclude 20S particles (6 nm) (D). Bars, 200 nm.
coid receptor and polyQ-expanded ataxin-1, respectively. Suppression of protein aggregation by DnaJ proteins in vitro requires a large molar excess of DnaJ protein (39); therefore, the endogenous levels of HDJ-2/HSDJ may not be sufficient to suppress aggregate formation by exogenously expressed ARQ48. To examine this issue further, HDJ-2/HSDJ was co-expressed with ARQ48. When HeLa cells were co-transfected with ARQ48 and HDJ-2/HSDJ, the number of ARQ48-positive cells containing aggregates was reduced ∼50% compared with cells transfected with empty vector (Table 2 ). This level of ARQ48 aggregate suppression by HDJ-2/HSDJ co-expression is very similar to that observed with mutant glucocorticoid receptor and mutant ataxin-1. Mutating the J domain of HDJ-2/HSDJ by deletion of amino acids 9-107 (HDJ-2/HSDJ∆450) eliminated HDJ-2/HSDJ-mediated aggregate suppression of mutant gluco- . In most cells, the cytoplasmic ARQ48 translocated to the nucleus within 20 min of hormone addition. However, in some cells several cytoplasmic aggregates were observed to form within 10 min of hormone addition (top cell). In addition, cytoplasmic ARQ48 aggregates appear to form during mitosis (B). Note that ARQ48 and wild-type AR (data not shown) appear to coat the chromosomes during mitosis. Two cells just completing mitosis demonstrate numerous cytoplasmic aggregates. A cell just entering mitosis [prometaphase cell at the top left of (B)] also exhibits aggregates distinct from the chromatin-associated GFP-ARQ48. The inset shows an anaphase cell also displaying cytoplasmic aggregates. The cells shown in (B) were fixed and counterstained with DAPI (blue) to label DNA and chromosomes. Live microscopy of ARQ48-expressing cells reveals the cytoplasmic aggregates to be remarkably mobile and demonstrates fusion events (C). Asterisks (*) mark examples of aggregates that fuse over the course of 1 h. All images were generated using deconvolution microscopy. (A), (B) and (C) show 3D reconstructions of a Z series through a majority of the cell. Bars, 10 µm.
corticoid receptor (35) and mutant ataxin-1 (20) . In the case of ARQ48, HDJ-2/HSDJ∆450 had intermediate effects, with 19% of co-transfected cells containing aggregates (Table 2) . When GFP-ARQ48 was used, the effect on aggregate formation by HDJ-2/HSDJ was more striking. Co-transfection of GFP-ARQ48 and HDJ-2/HSDJ constructs revealed a greater effect on HDJ-2/HSDJ-mediated aggregate suppression. In the presence of exogenous HDJ-2/HSDJ, the percentage of cells containing In ARQ48-positive cells, NEDD8 redistributes with both nuclear and cytoplasmic ARQ48 aggregates. In untransfected cells, NEDD8 has a very distinct, punctate distribution in the nucleus but redistributes into a much more homogeneous pattern in nuclei containing ARQ48 (I and J). The higher resolution images in (A)-(D), (I) and (J) were generated using deconvolution microscopy. Bars, 10 µm.
aggregates dropped from 37 to 15%. The HDJ-2/HSDJ∆450 deletion construct was more similar to the empty parent vector with aggregates in 32% of cells.
ARQ48 aggregates co-localize with NEDD8
Since intranuclear SBMA AR, ataxin-1 and huntingtin aggregates co-localize with ubiquitin in patient tissue, we examined whether ARQ48 cytoplasmic aggregates were ubiquitin positive.
In repeated experiments using several different ubiquitin antibodies and in parallel using ataxin-1 transfected cells that were ubiquitin positive, we have been unable to detect significant ubiquitin labeling of ARQ48 aggregates. However, ARQ48 aggregates labeled positively with NEDD8 ( Fig. 5G and H) , a protein that is 60% identical and 80% similar to ubiquitin (40, 41) . In untransfected HeLa cells, NEDD8 was very predominantly nuclear with a distinct punctate pattern (Fig. 5I ). In cells expressing nuclear ARQ48, NEDD8 specifically redistributed with the receptor throughout the nucleus (Fig. 5J ). This nuclear reorganization of NEDD8 was not restricted to ARQ48 but also occurred with ARQ22 and ARQ0 (data not shown), suggesting that under normal circumstances NEDD8 or a NEDD8-modified protein associates with AR. Recently, the ubiquitin conjugating enzyme E6AP has been shown to act as a steroid receptor coactivator (42) , suggesting that modifications by ubiquitinrelated proteins may play an important role in steroid receptor activity, and perhaps in SBMA pathology.
ARQ48 aggregates co-localize with PA700, but not 20S proteasome subunits
While little is known about the cellular function of NEDD8, it may play a similar role to ubiquitin in targeting proteins for degradation by proteasomes. One of the functions of ubiquitin modification is to target proteins for degradation by the multisubunit proteinase called the 26S proteasome (43) (44) (45) . The 26S proteasome is a complex supermacromolecular structure consisting of a proteolytic 20S core particle and two PA700 'cap' structures that form a 700 kDa multisubunit complex (46) (47) (48) (49) . The PA700 caps are involved in recognizing ubiquitin-modified substrates and targeting them for degradation in an ATP-dependent manner (48) . To test whether ARQ48 aggregates associate with any components of the proteasome, co-localization experiments were performed with antibodies recognizing the 20S core particle and the p31 protein subunit of the PA700 cap. In untransfected cells, the staining patterns of 20S and p31 antisera were very similar; both showing cytoplasmic and nucleoplasmic staining with a stronger signal in the nucleus ( Fig. 6A and C) . In ARQ48-transfected cells containing cytoplasmic aggregates, the distribution of the 20S subunit was largely unaffected (Fig. 6C  and D) . In contrast, immunostaining with the p31 antibody showed ARQ48 structures to be PA700 positive ( Fig. 6A and B) . This result was confirmed by using a second PA700 antibody that recognizes additional PA700 protein subunits (data not shown).
Higher resolution images using deconvolution microscopy clearly showed that p31/PA700 ( Fig. 6E and F) , but not 20S, accumulated in cytoplasmic ARQ48 aggregates ( Fig. 6G and H) . The ring-like staining pattern observed with anti-AR and other antibodies suggests that epitope accessibility in the interior of the aggregates is diminished. This raised the possibility that the diminished 20S staining observed in Figure 6 was due to poor anti-20S antibody penetration. To address this issue, immunogold labeling of ultrathin sections was performed using antibodies recognizing AR, p31 and 20S. Co-localization experiments were performed using different-sized gold particles to detect AR and proteasome subunits. ARQ48 and p31 were found to label throughout the cytoplasmic aggregates, save for the electronlucent holes (Fig. 3A) , which is consistent with the immunofluorescent results presented in Figures 1 and 6 . When co-labeling was performed with ARQ48 and 20S, the 20S labeling was dimin- Figure 6 . Preferential association of ARQ48 with PA700 proteasome activator caps versus 20S core particles. To detect association of ARQ48 aggregates with PA700 proteasome caps, cells were co-labeled with mouse anti-AR and rabbit anti-p31 (a protein subunit of PA700) (A and B). Note that much of the cellular PA700 is found associated with ARQ48 structures. To determine if 20S proteasome core particles associate with ARQ48, cells were co-labeled with mouse anti-AR and rabbit anti-20S. Interestingly, very little 20S staining was found associated with ARQ48 structures (C and D) indicating that functional 26S proteasomes are not likely within these structures. Higher resolution images using deconvolution microscopy confirms that ARQ48 aggregates are immunopositive for p31/PA700 (E and F), but not for 20S (G and H). Bars, 10 µm.
ished in comparison with ARQ48 and p31 (Fig. 3B) . Scant labeling of 20S was observed in the interior of some aggregates but was not enriched compared with the normal cytoplasmic distribution of 20S. These data indicate that ARQ48-positive structures have altered ratios of proteasome subunits and may lack the components necessary for a functional 26S proteasome. To address whether the altered distribution of proteasomes also occurred in nuclear ARQ48 patches, immunogold labeling was carried out in nuclei. The nuclear patches were found to stain positively for both AR and p31/PA700 (Fig. 3C ) but had reduced 20S staining (Fig. 3D) . These results indicate that both nuclear and cytoplasmic ARQ48 aggregates have altered stoichiometries of proteasome subunits that could lead to defects in proteolytic processing of misfolded ARQ48 in both the cytoplasm and nucleus.
ARQ48 aggregates sequester SRC1
ARs containing expanded polyQ repeats have lower transcriptional activity than wild-type ARs (50) (51) (52) (53) . This reduced activity could be directly due to the formation of protein aggregates that would reduce the amount of receptor available in the nucleus for Mancini, unpublished data) associates with ARQ48 (B) and redistributes to ARQ48 aggregates. Images were generated using deconvolution microscopy. Bars, 10 µm.
transcription. Alternatively, expanded glutamine tracts could have a more direct impact on transcription by affecting the way in which AR interacts with other transcriptional components. Steroid receptor coactivator 1 (SRC1) has been well studied in terms of its ability to interact with AR and other steroid receptors and enhance transcriptional activity (22, 29) . To test whether ARQ48 alters the cellular distribution of SRC1, we co-transfected ARQ48 and a functional GFP-SRC1 construct (S.A. Onate and M.A. Mancini, unpublished data) and examined the localization pattern of both proteins. ARQ48 co-localized with GFP-SRC1 in the nucleus in a hormone-dependent manner, as did wild-type AR. Interestingly, GFP-SRC1 was also found associated with ARQ48 cytoplasmic aggregates (Fig. 7) . These aggregates sequester a large proportion of the available GFP-SRC1, suggesting that polyQ AR retains the ability to interact with SRC1, presumably through its ligand binding domain.
DISCUSSION
The data presented here implicate failure to disperse and proteolyze misfolded protein as being responsible for the accumulation of ARQ48 aggregates. In our cell culture model, ARQ48 can accumulate in patches within the nucleus or in cytoplasmic aggregates. Many of the cytoplasmic aggregates containing nuclear proteins (NEDD8 and SRC1) likely form from a redistribution of the nuclear patches during cell division. ARQ48 aggregates accumulate molecular chaperones, specific proteasome components and mitochondria in what may be an attempt to refold or hydrolyze the misfolded protein. By co-expressing one of these required resources, namely HDJ-2/HSDJ, we assist the cellular response to these misfolded proteins and prevent aggregate formation in a large proportion of affected cells.
A complicating issue in these studies is that AR has a tendency to aggregate when overexpressed, as evidenced by the finding that even ARQ0 will form aggregates in some cells. It is important to note that there is a clear dependence upon polyglutamine tract length of the frequency of aggregate formation when ARs containing variable polyQs are expressed at similar levels (Table 1 ). This increased frequency of aggregate formation by polyQ ARs could possibly lead to the formation of aggregates over the course of 30-50 years in SBMA patients when a polyQ AR is expressed at physiological levels. We have examined the few cells that contain aggregates with ARQ0 and ARQ22 and find that they contain similar cellular components to the ARQ48 aggregates (data not shown). For this reason we feel that polyglutamines affect the frequency of aggregate formation by AR rather than resulting in AR aggregates that are substantially different in composition.
An emerging theme from disparate data is that several neurodegenerative diseases, including SBMA, SCAs, DRPLA and HD, as well as Alzheimer's disease, Parkinson's disease and prion-generated disease, result from accumulation of misfolded protein and associated cytoxicity (54) . Evidence suggests that altered distributions of molecular chaperones and proteasome components are associated with disease pathology. In some cases, addition of excess molecular chaperones can prevent formation of protein aggregates in vitro or in vivo. Recently, prion protein has been shown to interact with yeast hsp104 and GroEL chaperones in vitro, suggesting that this interaction may play a role in aggregate formation in vivo (55) . We demonstrate that ARQ48 aggregates accumulate the molecular chaperones Hsp70, Hsp90 and HDJ-2/HSDJ.
Co-expression of HDJ-2/HSDJ partially abrogates ARQ48 cytoplasmic aggregate formation as well as nuclear aggregate formation in two other proteins, a mutant glucocorticoid receptor (35) and ataxin-1[82Q] (20) . HDJ-2/HSDJ is a member of the Hsp40 family of molecular chaperones that function in concert with Hsp70 family members to assist in protein folding and prevention of protein misfolding (37, 38) . The finding that Hsp70 is induced and associated with aggregates of ARQ48 (Fig. 5) and ataxin-1 suggests that overexpression of HDJ-2/HSDJ suppresses aggregate formation by enhancing endogenous Hsp70 activity. In the case of ataxin-1, the N-terminal DnaJ domain, which interacts with Hsp70 and regulates its ATPase activity (56) , was shown to be important for this suppressive effect. Our results indicate that other regions of HDJ-2/HSDJ contribute to suppression of ARQ48 aggregate formation, since the DnaJ domain deletion has intermediate suppressive effects (Table 2 ).
An advantage of studying the effects of polyQ expansion in the AR as opposed to other glutamine repeat proteins is the wealth of data concerning its known transactivator function and associations with cofactors. The interaction of ARQ48, HDJ-2/HSDJ, Hsp70 and Hsp90 is not surprising given that these molecular chaperones interact with wild-type AR and regulate hormonedependent transactivation (27, 28) . Unliganded AR is predominantly cytoplasmic (30) and exists as a complex with molecular chaperones, including constitutive Hsp70, Hsp90 and HDJ2/HSDJ (24) . Addition of hormone results in shedding of cytoplasmic chaperones, conformational changes in the receptor and translocation to the nucleus where ligand bound receptor interacts with nuclear chaperones and components of the transcriptional apparatus (25) . Our live imaging results indicate that cytoplasmic aggregate formation can occur immediately after hormone addition and, probably, more prevalently during cell division. This suggests that a protective effect exists for the unliganded cytoplasmic receptor through interactions with endogenous chaperones. The cytoplasmic formation of GFP-ARQ48 aggregates observed immediately following hormone addition (and chaperone shedding) supports this notion.
The aggregates associated with SCA1, SCA3, HD and SBMA contain ubiquitin (14, 16, 17, 19) , suggesting that ubiquitination pathways are involved in disease formation and imply proteasome involvement as well. Direct interaction of proteasomes with nuclear aggregates has been demonstrated for ataxin-1 (20) and here we demonstrate an altered distribution of cellular PA700, a major component of the 26S proteasome, in both intranuclear accumulations of ARQ48 and in the cytoplasmic aggregates. Moreover, immunolabeling for the 20S core proteasome is greatly reduced both in cytoplasmic aggregates and intranuclear patches of ARQ48. Our finding that a significant portion of the PA700 activating cap complex is sequestered in ARQ48 aggregates, combined with the diminished levels of 20S core particle, strongly supports the idea that these aggregates contain low amounts of functional 26S proteasomes. This could prevent the cell from adequately processing the misfolded protein and lead to an accumulation of large aggregates that may be toxic to the cell. Perhaps as important, depletion or changes in the cellular pool of proteasome components would presumably distort the dynamics of proteasome assembly/disassembly and normal protein turnover. This could disrupt other cellular functions that require proteasomes, leading to toxic effects on the cell. It may also be important to note that in cells with numerous ARQ48 aggregates, mitochondria appear to be sequestered, suggesting that formation and/or maintenance of the aggregates are energy dependent. In this regard, it is interesting that many of the proteins that comprise the proteasome cap have ATPase activities (47, 57) .
The hormonal requirement for ARQ48 aggregate formation in tissue culture cells suggests that hormone is required for the formation of aggregates in patients affected with SBMA. Since the cause of SBMA is due to a gain of a toxic function by AR, this may help to explain why heterozygote female carriers, who have low levels of androgens compared with males, display few or no abnormalities (58) . Based on this, one would expect that anti-androgens would have a beneficial result in patients. However the available data, which are scant, indicate that hormonal treatments have little effect, either positive or negative, on patient condition. By the time SBMA is diagnosed, the accumulation of misfolded AR and the toxic effects this may have on motor neurons may be too great to overcome by the simple addition or removal of hormone. Moreover, testosterone has a trophic effect on motor neurons in vitro (59) , so removal of hormone or addition of anti-androgens could have an adverse affect. In our tissue culture model, we demonstrate that a number of cellular components, including proteasomes and molecular chaperones, are disrupted by mutant AR, thus providing more potential therapeutic targets.
In the case of ataxin-1, HDJ-2/HSDJ and proteasomes are found associated with nuclear ataxin-1 aggregates in transfected tissue culture cells, transgenic mice and SCA1 patient tissue (20) . This suggests that tissue culture cells can serve as a valid model to study the interactions of aggregates with chaperones and proteasomes. A recent report has shown that SBMA patients have nuclear aggregates that are very similar to the nuclear aggregates found in SCA and HD patients (19) . These nuclear aggregates only label with antibodies recognizing the N-terminus of AR but not with antibodies to other regions of AR. One of the antibodies used that did not label the aggregates corresponds to roughly the same epitope we use here in our experiments. Our attempts to identify AR aggregates in patient tissue have been equivocal, which may be due in part to poor preservation of tissue as well as epitope inaccessibility of our antibody. We identify here both cytoplasmic and nuclear aggregates that are revealed to have similar ultrastructure by electron microscopy. In most cases, cytoplasmic aggregates arise following mitosis, indicating that they form first in the nucleus. Also, the predominantly nuclear NEDD8 and SRC1 are found to redistribute to cytoplasmic aggregates, implying that the ARQ48 found in these aggregates has a nuclear origin. The occurrence of cytoplasmic aggregates could result from the tissue culture cells used in this experiment being capable of dividing, unlike the affected neurons in SBMA patients. Regardless, the similarity between the nuclear and cytoplasmic aggregates we observe in terms of ultrastructure and association with proteasome subunits suggests that nuclear aggregates would also perturb many of the same cellular functions that we hypothesize for the cytoplasmic aggregates.
We present here a number of factors associated with ARQ48 aggregates that by themselves, or together, could affect normal cell metabolism. First, the association of ARQ48 with molecular chaperones could directly disrupt the cell's ability to deal with other misfolded proteins and activate the stress response. Secondly, disruption of the proteasome pathway could affect the dynamics of protein turnover and lead to defects in other cellular functions requiring proteasomes. Thirdly, the association of mitochondria with cytoplasmic aggregates indicates that these aggregates place a large energy demand on the cell. This energy is likely being used by the chaperones and proteasomes in an attempt to refold or proteolyze misfolded ARQ48. Finally, we demonstrate that ARQ48 alters the distribution of SRC1, suggesting that ARQ48 aggregates could have a global effect on transcription pathways involving this coactivator in addition to affecting androgen-mediated transcription. These results indicate that a number of cellular pathways are disrupted in cells containing misfolded protein aggregates and provide several targets for therapeutic approaches. We demonstrate that overexpression of a molecular chaperone can partially prevent aggregate formation in tissue culture cells; however, finding a way to apply this observation to patients will be a challenge. Factors that affect proteasome or transcription pathways may also be likely candidates for disease treatment and should be further explored.
MATERIALS AND METHODS
Mammalian expression plasmids
The original AR cDNA (60) was subcloned in the CMV3 vector (CMV-AR) and contains 22 glutamines. AR receptor constructs containing 0 or 48 repeats were obtained by site-directed mutagenesis utilizing the unique restriction sites NarI and AflII, which surround the polyQ repeat (61) . The Q48 fragment was PCR amplified from the genomic DNA of an SBMA patient and subcloned in a CMV-AR plasmid previously digested with NarI and AflII. To generate GFP-AR constructs, PCR was used to amplify the AR DNA spanning amino acids 1-108 with a 5′ KpnI (5′GFP-AR, AGCTGGTACCATGGAAGTGCAGTTAGGGCTG) site and a 3′ BamHI site (3′GFP-AR, AGCTGGATCCTTGGGGAGAAC-CATCCTCAC). This PCR fragment was subcloned into the pEGFP-C1 vector (Clontech, Palo Alto, CA) using the KpnI and BamHI sites. The AR DNAs containing 0, 22 and 48 glutamine repeats were cut out of the original AR vectors using XmaI (located 5′ to the repeats) and BglII. These segments were subcloned into the pEGFP-C1-AR(amino acids 1-108) vector using the XmaI and BamHI sites to generate the vectors GFP-ARQ0, GFP-ARQ22 (wt) and GFP-ARQ48. Full-length human HDJ-2/HSDJ and ∆450 (deletion of amino acids 9-107) (35) were subcloned into the pFlag-CMV-2 vector (Sigma, St Louis, MO) as described previously (20) . GFP-SRC1 was generated by PCR amplification of the GFP sequence from pEGFP-C1 (Clontech) using the primers 5′EGFP (CATGGTACCATGGTGAGCAAGGGCGAGGA) and 3′EGFP (CTGCAGAACCACCACACTGGACTTGTACAGCTCGTCC-ATGC) to create a GFP fragment with a 5′ KpnI site and a 3′ BstXI site used for subcloning into the pCR3.1-hSCR1a vector encoding human SRC1 (29) .
Cell labeling
Twenty-four hours prior to transfection, HeLa cells were plated onto poly-D-lysine-coated coverslips in 35 mm wells at a concentration of 10 5 cells/well. Transient expression of AR, HDJ-2/HSDJ and GFP-SRC1 vectors was accomplished using a calcium phosphate transfection kit (5′-3′, Boulder, CO). Twelve hours after transfection, cells were shocked with 10% DMSO and allowed to recover for 6 h prior to addition of hormone. In some cases, cells were synchronized following transfection by addition of 0.1 mg/ml colcemid for 4 h, after which mitotic cells were harvested and replated for 2 h before hormone addition. Cells were incubated for 16 h with 10 -9 R1881 and fixed in 4% formaldehyde in PEM (80 mM K-PIPES, 5 mM EGTA, 2 mM MgCl 2 , pH 6.8) for 30 min at 4_C, quenched in 1 mg/ml NaBH 4 in PEM and permeabilized for 30 min in 0.5% Triton X-100 in PEM. Coverslips were blocked for 1 h at room temperature in 5% dry milk in TBST (20 mM Tris-HCl, 150 mM NaCl, 0.1% Tween 20, pH 7.4) and incubated for 2 h at room temperature with primary mouse monoclonal anti-AR (generated against the peptide CSTEDTAEYSPFKGGYTK corresponding to amino Hsp90 was detected with a mouse monoclonal anti-Hsp90 antibody (1:500; StressGen). Endogenous HDJ-2/HSDJ was detected using mouse monoclonal anti-HDJ-2/DNAJ (1:200; Neomarker, Fremont, CA). Proteasome subunits were detected with rabbit polyclonal anti-20S antibody, rabbit polyclonal anti-p31 antibody, rabbit polyclonal anti-p28 antibody or chicken anti-PA700 antibody all diluted 1:500 (62, 63) . NEDD8 was detected using a rabbit polyclonal anti-NEDD8 antibody [1:500; a gift from E. Yeh (41) ]. The FLAG epitope in expressed HDJ-2/HSDJ was detected using the mouse monoclonal antibody M2 (1:2000; Sigma). Primary antibodies were detected using the appropriate Texas Red-or FITC-conjugated secondary antibodies (1:600; Southern Biotechnologies, Birmingham, AL) recognizing mouse, rabbit or chicken primary antibodies. In some cases (Hsp90 and HDJ-2/HSDJ), co-localization was performed using GFP-labeled AR instead of AR antibody since both primary antibodies were made in mouse. Cells were counterstained for 1 min in DAPI (1 µg/ml) in TBST and mounted in Slow Fade reagent (Molecular Probes, Eugene, OR).
Fluorescent and deconvolution microscopy
Conventional immunofluorescence microscopy and DIC were performed using a Zeiss Axiophot microscope. Deconvolution microscopy was performed on a Zeiss Axiovert S100 TV microscope and a DeltaVision Restoration Microscopy System (Applied Precision, Issaquah, WA). A Z series of focal planes was digitally imaged and deconvolved with the DeltaVision con-strained iterative algorithm (64) to generate high resolution images. All image files were digitally processed for presentation using Adobe Photoshop and printed at 300 d.p.i. using a Codonics NP 1600 dye diffusion printer.
Western blots
Following transfection and hormone addition, cells were lysed in 1× Laemmli sample buffer and samples (∼10 5 cells/well) were electrophoresed on a 4-16% SDS-PAGE gel and transferred to Immobilon (Millipore, Bedford, MA) using a liquid transfer apparatus (Bio-Rad, Hercules, CA). The membrane was blocked for 1 h in 5% dry milk in TBST, incubated with anti-AR mouse monoclonal antibody (0.1 µg/ml) for 2 h, washed in TBST, incubated with horseradish peroxidase-conjugated secondary antibody (1:2000; Pierce, Rockford, IL) for 1 h and washed in TBST. Signal was detected using the ECL kit (Amersham, Arlington Heights, IL).
Immunogold labeling and EM
Transfected cells were fixed for 1 h in 0.1 M sodium cacodylate buffer, pH 7. 3, containing either 4% paraformaldehyde and 0.1% glutaraldehyde (immunogold labeling studies) or 2% paraformaldehyde and 2% glutaraldehyde, followed by post-fixation for 1 h in 1.0% osmium tetroxide in the same buffer (ultrastructural studies). Fixed cells were gradually dehydrated in ethanol to a final concentration of 100% and embedded in LR White (EM Sciences, Fort Washington, PA) for imunolabelling or in Spurr's (EM Sciences). Ultrathin sections were cut on an RMC MT6000-XL and stained with lead citrate and ethanolic uranyl acetate for ultrastructural studies and examined at 75 kV with a Hitachi H7000 TEM.
For immunogold labeling, sections on nickel grids were incubated for 15 min in 10% normal goat serum (Sigma) in 0.05 M Tris containing 150 mM NaCl, 0.1% Tween 20 and 1.0% bovine serum albumin (TBST-BSA). Grids were transferred directly to mouse anti-AR diluted 1:75 in TBST-BSA for 1 h, washed in TBST and incubated in 12 nm gold-labeled goat anti-mouse antibody (Jackson ImmunoResearch Laboratories, West Grove, PA) diluted 1:30 in TBST-BSA, followed by extensive washing in TBST. The sections were then incubated for 1 h in one of the following rabbit antibodies diluted in TBST-BSA: P31, 1:75; 20S, 1:50; PA700, 1:50. This was followed by washing in TBST. The sections were incubated for 1 h in 6 nm gold-labeled goat anti-rabbit antibody diluted 1:30, then washed in TBST followed by distilled water. The grids were stained for 3-5 s in ethanolic uranyl acetate and examined at 75 kV with a Hitachi H7000 TEM.
